Effect of Camel Milk on Chronic Hepatitis C

• Status: Completed
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Camel milk as the new modality for treatment of chronic hepatitis C. The purpose of this study is to evaluate effectiveness and safety of camel milk in combination with Peginterferon Alfa-2a and Ribavirin in genotype 2,3 chronic hepatitis C virus .

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mashhad University of Medical Sciences
• Treatments: Interferon-alpha; Peginterferon alfa-2a; Ribavirin

Criteria

Inclusion Criteria:

• HCV (hepatitis C virus ) RNA positive

• Age age groups (18 to 70 years)

Exclusion Criteria:

• Ongoing pregnancy or breast feeding

• Hx of HCC(hepatocellular carcinoma )

• Hx of alcoholic liver disease

• Hx of bleeding from esophageal varices

• Hx of hemochromatosis

• Hx of autoimmune hepatitis

• Hx of Suicidal attempt

• Hx of cerebrovascular dis

• Hx of severe retinopathy

• Hx of severe psoriasis

• Hx of scleroderma

• Hx of metabolic liver disease

• Hx of SLE(systemic lupus erythematosus )